For example, high levels of ANRIL expression were negatively correlated with chemotherapeutic responses in those patients with CRC undergoing treatment with a 5-FU-based regimen such that inhibiting ANRIL may represent a viable approach to chemosensitization(Zhang et al. 2018). Here, CDKN2B-AS1 is linked to colorectal carcinoma.